Molecular and biochemical pharmacology of mitoxantrone
- 31 December 1983
- journal article
- research article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 10, 3-11
- https://doi.org/10.1016/0305-7372(83)90016-6
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Inhibition of adriamycin-stimulated microsomal lipid peroxidation by mitoxantrone and ametantrone, two new anthracenedione antineoplastic agentsBiochemical and Biophysical Research Communications, 1982
- The Anticancer Agent Adriamycin Can Be Actively Cytotoxic Without Entering CellsScience, 1982
- Comparison of the interaction of antineoplastic aminoanthraquinone analogs with DNA using competitive fluorescence polarizationLife Sciences, 1982
- Sister-chromatid exchange and chromosomal aberrations by DHAQ and related anthraquinone derivatives in Chinese hamster ovary cellsMutation Research/Genetic Toxicology, 1982
- Adriamycin-induced compaction of isolated chromatinBiochemical Pharmacology, 1982
- DNA-Binding Specificity and RNA Polymerase Inhibitory Activity of Bis(aminoalkyl)anthraquinones and Bis(methylthio)vinylquinolinium IodidesJournal of Pharmaceutical Sciences, 1982
- Effect of 1,4-dihydroxy-5,8-bis (2-(2-hydroxyethylamino) ethyl amino)-9,10-anthracenedione(dihydroxyanthraquinone) on the replication of simian virus 40 chromosomeBiochemical and Biophysical Research Communications, 1981
- Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10-anthracenedione, with nucleic acidsBiochemical Pharmacology, 1981
- Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenedionesJournal of Medicinal Chemistry, 1979
- Evaluation of the binding of some substituted anthraquinones and naphthacenequinones to DNAJournal of Pharmacy and Pharmacology, 1976